相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Structure-Based Design, Synthesis, and Biological Evaluation of New Triazolo[1,5-a]Pyrimidine Derivatives as Highly Potent and Orally Active ABCB1 Modulators
Shuai Wang et al.
JOURNAL OF MEDICINAL CHEMISTRY (2020)
Revisiting the role of ABC transporters in multidrug-resistant cancer
Robert W. Robey et al.
NATURE REVIEWS CANCER (2018)
Repurposing Albendazole: new potential as a chemotherapeutic agent with preferential activity against HPV-negative head and neck squamous cell cancer
Farhad Ghasemi et al.
ONCOTARGET (2017)
Synthesis and biological evaluation of N-(carbobenzyloxy)-L-phenylalanine and N-(carbobenzyloxy)-L-aspartic acid-β-benzyl ester derivatives as potent topoisomerase IIα inhibitors
Xiaoyan Han et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2017)
BDDCS, the Rule of 5 and drugability
Leslie Z. Benet et al.
ADVANCED DRUG DELIVERY REVIEWS (2016)
Diversity oriented synthesis of benzimidazole-based biheterocyclic molecules by combinatorial approach: a critical review
Barnali Maitiand et al.
RSC ADVANCES (2016)
Genomic and transcriptomic profiling of resistant CEM/ADR-5000 and sensitive CCRF-CEM leukaemia cells for unravelling the full complexity of multi- factorial multidrug resistance
Onat Kadioglu et al.
SCIENTIFIC REPORTS (2016)
2((Benzimidazol-2-yl)thio)-1-arylethan-1-ones: Synthesis, crystal study and cancer stem cells CD133 targeting potential
Hatem A. Abdel-Aziz et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2015)
Discovery of a potent and highly fluorescent sirtuin inhibitor
Y. K. Yoon et al.
MEDCHEMCOMM (2015)
Dasatinib reverses the multidrug resistance of breast cancer MCF-7 cells to doxorubicin by downregulating P-gp expression via inhibiting the activation of ERK signaling pathway
Ting Chen et al.
CANCER BIOLOGY & THERAPY (2015)
ABC Transporters in Multidrug Resistance and Pharmacokinetics, and Strategies for Drug Development
Young Hee Choi et al.
CURRENT PHARMACEUTICAL DESIGN (2014)
Anti-Proliferation Effects of Benzimidazole Derivatives on HCT-116 Colon Cancer and MCF-7 Breast Cancer Cell Lines
Mohammed Hadi Al-Douh et al.
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION (2012)
Three Decades of P-gp Inhibitors: Skimming Through Several Generations and Scaffolds
A. Palmeira et al.
CURRENT MEDICINAL CHEMISTRY (2012)
Computational models for predicting substrates or inhibitors of P-glycoprotein
Lei Chen et al.
DRUG DISCOVERY TODAY (2012)
Carotenoids reverse multidrug resistance in cancer cells by interfering with ABC-transporters
Safaa Yehia Eid et al.
PHYTOMEDICINE (2012)
Digitonin synergistically enhances the cytotoxicity of plant secondary metabolites in cancer cells
Safaa Yehia Eid et al.
PHYTOMEDICINE (2012)
Development of Safe One-Pot Synthesis of N-1-and C-2-Substituted Benzimidazole via Reductive Cyclization of o-Nitroarylamine Using Na2S2O4
Shinichi Oda et al.
ORGANIC PROCESS RESEARCH & DEVELOPMENT (2012)
Novel Insights into Targeting ATP-Binding Cassette Transporters for Antitumor Therapy
L. Gatti et al.
CURRENT MEDICINAL CHEMISTRY (2011)
Zosuquidar, a novel modulator of P-glycoprotein, does not improve the outcome of older patients with newly diagnosed acute myeloid leukemia: a randomized, placebo-controlled trial of the Eastern Cooperative Oncology Group 3999
Larry D. Cripe et al.
BLOOD (2010)
Tetrandrine prevents acquired drug resistance of K562 cells through inhibition of mdr1 gene transcription
Huiling Shen et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2010)
Multiple Drug Resistance Mechanisms in Cancer
Bruce C. Baguley
MOLECULAR BIOTECHNOLOGY (2010)
Recent Advances in the Development of P-gp Inhibitors
Christiane Baumert et al.
ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY (2009)
Bendamustine in B-Cell Malignancies: The New 46-Year-Old Kid on the Block
Varsha Gandhi et al.
CLINICAL CANCER RESEARCH (2009)
Doxorubicin: The Good, the Bad and the Ugly Effect
Cristina Carvalho et al.
CURRENT MEDICINAL CHEMISTRY (2009)
Carbendazim Inhibits Cancer Cell Proliferation by Suppressing Microtubule Dynamics
Mythili Yenjerla et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2009)
Diversity oriented syntheses of fused pyrimidines designed as potential antifolates
Colin L. Gibson et al.
ORGANIC & BIOMOLECULAR CHEMISTRY (2009)
Bendamustine (Treanda) displays a distinct pattern of cytotoxicity and unique mechanistic features compared with other alkylating agents
Lorenzo M. Leoni et al.
CLINICAL CANCER RESEARCH (2008)
Synthesis of the second generation photoaffinity probes of tautomycin
Magne O. Sydnes et al.
TETRAHEDRON (2007)
Role of anthracyclines in the era of targeted therapy
Hernan Cortes-Funes et al.
CARDIOVASCULAR TOXICOLOGY (2007)
Targeting multidrug resistance in cancer
G Szakács et al.
NATURE REVIEWS DRUG DISCOVERY (2006)
Phase-I/II study to evaluate dose limiting toxicity, maximum tolerated dose, and tolerability of bendamustine HCl in pre-treated patients with B-chronic lymphocytic leukaemia (Binet stages B and C) requiring therapy
T Lissitchkov et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2006)
Design, synthesis, and biological activity of m-tyrosine-based 16-and 17-membered macrocyclic inhibitors of hepatitis C virus NS3 serine protease
KX Chen et al.
JOURNAL OF MEDICINAL CHEMISTRY (2005)
ABC transporters as multidrug resistance mechanisms and the development of chemosensitizers for their reversal
Cheol-Hee Choi
CANCER CELL INTERNATIONAL (2005)
Strong protective action of Copper(II) N-substituted sulfonamide complexes against reactive oxygen species
M González-Alvarez et al.
JOURNAL OF INORGANIC BIOCHEMISTRY (2004)
A novel antibacterial 8-chloroquinolone with a distorted orientation of the N1-(5-amino-2,4-difluorophenyl) group
Y Kuramoto et al.
JOURNAL OF MEDICINAL CHEMISTRY (2003)
Multidrug resistance in cancer: Role of ATP-dependent transporters
MM Gottesman et al.
NATURE REVIEWS CANCER (2002)
分享论文
